Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of ondansetron oral dissolving film for prevention of chemotherapy-, radiotherapy-, and postoperative nausea and vomiting
ChiCTR2400089063Phase 4Recruiting
- Sponsor
- Affiliated Cancer Hospital of Nanjing Medical University
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ondansetron in nausea ((none)), Vomiting, postoperative nausea and vomiting (PONV) and 2 more (2 cohorts), sponsored by Affiliated Cancer Hospital of Nanjing Medical University. Primary endpoint: Incidence and severity of nausea and vomiting in the acute phase. Started Aug 2024; status: recruiting.
02
Drugs
ondansetron
03
Conditions
nausea ((none))Vomitingpostoperative nausea and vomiting (PONV)chemotherapy-induced nausea and vomiting (CINV)post-radiation nausea and vomiting (RINV)
Beyond the preview
Go deeper on ChiCTR2400089063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089063.